BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research Annual Meeting 2021 Biotech Investing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses over $100K to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
 CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal... Biotech Investing
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors Biotech Investing
Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference Biotech Investing
Bristol Myers Squibb Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Aurinia Presents Data Demonstrating LUPKYNIS Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Biotech Investing
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival Biotech Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XL Fleet Corp., Bellus Health, Neptune Wellness, and Sequential Brands and Encourages Investors to Contact the Firm Biotech Investing
